Molecular Biologists explore the molecular foundations of living organisms, focusing on how biological molecules like DNA, RNA, and proteins work together to control cellular processes. Their research delves into the complexities of gene expression, mutation, and protein synthesis, seeking to understand how molecular changes can affect health, development, and disease. By utilizing cutting-edge technologies such as gene sequencing, CRISPR gene editing, and advanced microscopy, Molecular Biologists uncover the underlying mechanisms of genetic regulation and cellular function. Their discoveries are foundational to multiple fields, including genetics, biochemistry, and pharmacology.
Beyond their research, Molecular Biologists collaborate with other scientists, healthcare professionals, and industries to apply their findings to real-world challenges. Their work plays a key role in the development of gene therapies, personalized medicine, and diagnostic tools. By identifying molecular biomarkers and studying genetic disorders, they contribute to the creation of treatments for a wide range of diseases, including cancer, genetic conditions, and infectious diseases. Their research also paves the way for innovations in biotechnology, agriculture, and environmental science, such as the development of genetically modified crops or sustainable biofuels. As experts at the forefront of scientific discovery, Molecular Biologists are instrumental in advancing our understanding of life and improving health outcomes globally.
 
                                 
                                 
                                 
                                 
                                 
                                 
                             
                             
                             
                            
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Mathematical modeling of COVID-19 dynamics in a West African context
Christabel Emaeyak James, University of Glasgow, United Kingdom
Title : Severe influenza and other related respiratory infection cases during Omicron era in Japan
Masafumi Seki, Saitama Medical University International Medical Center, Japan